Petter Attia, M.D.

Peter Attia, M.D. | NuSI President, Director

Peter is the President and co-Founder of the Nutrition Science Initiative (NuSI). Peter is a former McKinsey & Company consultant, where he was a member of both the corporate risk and healthcare practices. Prior to McKinsey, Peter spent five years at the Johns Hopkins Hospital as a general surgery resident, where he was the recipient of several prestigious awards and the author of a comprehensive review of general surgery. Peter also spent two years at the National Institutes of Health as a surgical oncology fellow at the National Cancer Institute under Dr. Steve Rosenberg, where his research focused on the role of regulatory T cells in cancer regression and other immune-based therapies for cancer. Peter is a 2012/2013 recipient of the French-American Foundation Young Leader’s Fellowship, which recognizes the most promising leaders in the United States and France under 40.  Peter earned his M.D. from Stanford University and holds a B.Sc. in mechanical engineering and applied mathematics from Queen’s University in Kingston, Ontario, Canada, where he also taught and helped design the calculus curriculum.


David Berkowitz

David Berkowitz | Director

David is the Chief Risk and Strategy Officer for Ziff Brothers Investments in New York, NY where he is responsible for the firm’s risk management and investment strategy. Previously, David was the Managing Director at Private Markets Group where he was responsible for a broad range of investment disciplines including private debt and equity investing as well as the development and implementation of alternative investment strategies. Prior, he managed a private investment partnership and was Chief Investment Officer for a New York-based family office. David has also worked at Union Carbide Corporation and Amoco Corp.

David holds both a B.S. in Chemical Engineering and a M.S. in chemical engineering practice from the Massachusetts Institute of Technology, and an M.B.A. from the Harvard Business School, where he was a Baker Scholar and was awarded the Loeb Prize for Excellence in Finance. David resides in New York City with his wife and two children.


Bjorkland150

Victoria B. Bjorklund | Director

Victoria is a Retired Partner at Simpson Thacher & Bartlett LLP where she founded and headed the Firm’s Exempt Organizations Group, which advises public charities, private foundations, boards, and donors. She was named “2014 Nonprofit Lawyer of the Year” by her peers in Best Lawyers magazine. The 2013 Legal 500 described her as “[t]he highly respected … dean of the practice.” In 2012, she received the Vanguard Award for Lifetime Achievement and Commitment to Nonprofit Law from the American Bar Association’s Business Law Section, recognizing her role in development of the field. She was honored in 2002 as the ABA Tax Section “Pro Bono Lawyer of the Year” in recognition of her 9/11 work.

Victoria is a director of the Robin Hood Foundation, where she chairs the Robin Hood Sandy Relief Fund and is a founding director of the U.S. arm of Doctors Without Borders. In addition, she is a director of the American Friends of the Louvre, the Louvre Endowment, Friends of Fondation de France, the Institute for Advanced Study in Princeton, Princeton University, and the Lawyers Committee for Civil Rights Under Law. She speaks and writes frequently on exempt-organization subjects and is the co-author with Jim Fishman and Dan Kurtz of New York Nonprofit Law and Practice (LexisNexis, 2d Ed. 2007 and annual supplements). She currently teaches The Law of Nonprofit Organizations at Harvard Law School. She earned her J.D. at Columbia University School of Law, a Ph.D. in Medieval Studies from Yale University, and a B.A., magna cum laude, from Princeton University, where she graduated in three years and was elected to Phi Beta Kappa.


Jonathan Lim, M.D.

Jonathan Lim, M.D. | Director

Jonathan is the Managing Partner and Founder of City Hill Ventures, LLC, a health care investment firm established in 2010.  Previously, he was President, CEO, and Board Director of Halozyme Therapeutics, Inc. (NASDAQ: HALO). Under his leadership, Halozyme achieved two U.S. FDA approvals, and built a pipeline of two Phase 3, two Phase 2, and two Phase 1 product candidates. Previously, Jonathan was a consultant at McKinsey & Company.  He earned B.S. and M.S. degrees from Stanford University.  He received his M.D. from McGill University and conducted his residency in surgery at New York Hospital-Cornell.  He earned his M.P.H. from Harvard University, where he was awarded an NIH Postdoctoral Fellowship.


John Shilling, M.D.

John Schilling, M.D. | Chairman of the Board

John is Partner and member of the Global Operations team at TPG Capital.  At TPG, John has responsibility for leading the Operations efforts for and supporting the investment activity in the Healthcare Portfolio Companies.  John was a Corporate Officer and Vice President of Sales and Marketing for the US Pharmaceutical business at Abbott Laboratories.  While at Abbott, he had P&L responsibility for multiple franchises, including Primary Care, Endocrinology, Oncology, Renal, Virology, Mature Products, along with contracting for US Managed Care and Trade.  Before joining Abbott, John was a partner at McKinsey and Company, where he served clients across the healthcare landscape – focusing on growth, mergers and acquisitions, commercialization of new products and services, and corporate strategy.  John received his Bachelor’s degree with Distinction in Biomedical and Electrical Engineering from Duke University, his Master’s degree in Biomedical Engineering from Johns Hopkins University, where he was a Bozzelli Scholar, and his M.D. with Honors from the University of Chicago.  Following medical school, John conducted his residency training in General Surgery at the Johns Hopkins Hospital and School of Medicine.


Saum Sutaria, M.D.

Saum Sutaria, M.D. | Director

Saum is a senior Director of McKinsey & Company. His area of expertise is the healthcare sector with a special emphasis in healthcare delivery and financing. He leads the Provider Practice in the Americas, which covers hospital systems, physician groups, ambulatory care models, integrated delivery, and government led delivery. He has served over 15 major health systems across over 75 markets as well as healthcare systems globally. Previously, Saum held an associate clinical faculty appointment at the University of California, San Francisco.  He received his B.S. and B.A. from University of California, Berkeley, where he received the University Medal in his year of graduation, and his M.D. from University of California, San Diego, where he was a Howard Hughes Medical Institute Fellow. He did his training in internal medicine and cardiology  at University of California, San Francisco.


Gary Taubes

Gary Taubes | Director

Gary, co-Founder of the Nutrition Science Initiative, is a science and health journalist and currently a Robert Wood Johnson Foundation Independent Investigator in Health Policy Research at the U.C. Berkeley School of Public Health. He is the author of Why We Get Fat and Good Calories, Bad Calories. Gary has been a contributing correspondent for the journal Science since 1993, and has contributed articles as a freelancer to The Atlantic Monthly, The New York Times Magazine, Esquire, Slate, and numerous other publications. His 1997 book, Bad Science was a New York Times Notable Book and a finalist for the Los Angeles Times Book Awards. He is the only print journalist to be a three-time winner of the National Association of Science Writers science-in-society journalism award. Gary received his B.S. in physics from Harvard University, his M.S. in engineering from Stanford University, and his M.S. in journalism from Columbia University.


  • Donate or get involved Connect and talk to us